ATryn, a recombinant human anti-thrombin-α produced in transgenic goats' milk, validates “the regulatory process they [FDA] just codified in the guidance,” says Barbara Glenn, who is managing ...

The drug, ATryn, is a protein replacement treatment for people afflicted with a rare blood-clotting disorder called hereditary antithrombin deficiency, who are at risk of thrombosis. It is made by ...

View Full Profile. Learn about our Editorial Policies. US Food and Drug Administration (FDA) approval of the GM chicken for the production of Kanuma “shows that the ATryn goats weren’t just a one-off, ...

Atryn was rejected because GTC simply did not ... In cows and sheep and GTC's bioreactor of choice, the goat, the oligosaccharide decoration on proteins typically contains N-glycolylneuraminic ...